BPC-157 (Body Protection Compound)
Pentadecapeptide BPC-157 | Tissue & Repair Pathway Research
₱2300.00₱1700.00
BUY NOW |
|---|
Third-party Tested | Free Shipping Nationwide | COA Verified |
Active Batch | Purity |
BPC-SL3R62-10 | > 99.5% |
All products are third-party tested by our manufacturer before release and are submitted again to an independent third-party laboratory upon arrival in the Philippines. This additional testing helps verify identity, purity, heavy metals, residual solvents, microbial safety, and overall batch quality before distribution. If independent testing shows purity below 99%, we offer a money-back guarantee.
BPC-157 is an investigational synthetic peptide being studied for its potential role in tissue-repair, gastrointestinal, and recovery-related research. It is a 15–amino-acid peptide, often described as a “body protection compound,” and is mainly discussed in preclinical research models involving soft tissue, tendon, ligament, muscle, wound-healing, and gut-barrier pathways.
Unlike metabolic peptides such as tirzepatide or retatrutide, BPC-157 is not designed around GLP-1, GIP, or glucagon receptor activity. Instead, scientific interest centers on its possible interaction with repair-related signaling, angiogenesis, nitric oxide pathways, inflammation response, and gastrointestinal protection mechanisms. Most published evidence is still based on animal and laboratory studies, and researchers continue to emphasize the need for well-designed human trials before safety or effectiveness can be established.
BPC-157 remains investigational and is not approved for human clinical use by major regulatory authorities. It is also prohibited in sport under the World Anti-Doping Agency framework as an unapproved substance.
Potential research interests observed mainly in preclinical studies
Tissue-repair research
BPC-157 is widely discussed in animal and laboratory research involving tendon, ligament, muscle, and wound-healing models. This has made it one of the most commonly referenced peptides in repair and recovery research.
Gastrointestinal support research
Because BPC-157 is associated with gastric-protection models, it is often studied in relation to gut integrity, ulcer models, intestinal injury, and gastrointestinal barrier research.
Soft-tissue and musculoskeletal interest
Research attention often focuses on connective-tissue models, including tendons, ligaments, and muscle injury pathways. A recent review noted strong preclinical interest but also emphasized that human evidence remains limited.
Inflammation-response research
BPC-157 is often discussed in experimental models involving inflammatory signaling and tissue-stress response. These findings are not the same as proven clinical benefits in humans.
Blood-flow and angiogenesis-related pathways
Some studies examine BPC-157 in relation to nitric oxide signaling, vascular response, and blood-vessel formation during tissue-repair models.
Recovery-oriented experimental models
BPC-157 is commonly researched in models involving injury response, recovery timing, and tissue-protection mechanisms, which explains its popularity in peptide research communities.
Stable peptide structure
BPC-157 is frequently described as a relatively stable peptide sequence, which is one reason it continues to receive attention in laboratory and preclinical research.
Broad investigational use
Because it is studied across gut, tissue, tendon, and wound-repair models, BPC-157 is often viewed as a broad research peptide rather than a pathway-specific metabolic peptide.
Limitations and risks observed or discussed
Limited human clinical evidence
Most BPC-157 findings come from animal or laboratory studies. Current reviews highlight the need for well-designed human trials before claims about safety, dosing, or effectiveness can be made.
Not an approved medication
BPC-157 is not approved for human clinical use by major regulatory authorities. It should not be marketed or used as a treatment for injury, pain, gut disease, or recovery.
Unknown long-term safety profile
Because controlled human research is limited, long-term safety, drug interactions, appropriate dosing, and risk groups are not well established.
Possible risks from unregulated products
Products sold online may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, or lack of regulated manufacturing oversight.
Athlete compliance concerns
BPC-157 is prohibited under WADA’s prohibited framework, and USADA warns that it is an experimental peptide not approved for human clinical use.
Claims may exceed the evidence
Many online claims around “healing,” “injury repair,” or “gut repair” go beyond what has been proven in controlled human trials.
Human use requires medical and regulatory caution
Because BPC-157 remains investigational, it should only be handled within appropriate research settings and should not be used as a substitute for approved medical care.
Website-safe closing line
BPC-157 is scientifically interesting for tissue-repair, gastrointestinal, and recovery-related research, but current evidence is primarily preclinical and its human safety profile remains insufficiently established. BPC-157 is not approved for human clinical use and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.
